Hematology TimesDecitabine produces responses in high-risk MDS, AMLNovember 29, 2016AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesInflammation may predict transformation to AMLOctober 5, 2016AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesTeva launches generic imatinib tablets in USAugust 8, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
Hematology TimesMethod provides more accurate diagnosis of MDS, team saysAugust 3, 2016AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Hematology TimesRadiologists no longer have higher risk of cancer-related deathJuly 21, 2016AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLMyelodysplastic Syndrome
Hematology TimesImmunotherapy may benefit relapsed HSCT recipientsJuly 14, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAML
Hematology NewsIpilimumab may restore antitumor immunity after relapse from HSCTJuly 13, 2016AMLALLMultiple MyelomaMyelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsMidostaurin cut organ damage in systemic mastocytosisJune 29, 2016Myelodysplastic SyndromeRare DiseasesLeukemia, Myelodysplasia, Transplantation
Hematology NewsLenalidomide eliminated transfusion dependence for a minority of non-del(5q) MDS patientsJune 29, 2016Myelodysplastic Syndrome
Hematology TimesStudy: CMV doesn’t lower risk of relapse, deathJune 29, 2016AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic SyndromeCML
Hematology TimesDrug enables transfusion independence in lower-risk MDSJune 24, 2016AnemiaLeukemia, Myelodysplasia, TransplantationBlood BankingMyelodysplastic Syndrome
Hematology TimesESA benefits lower-risk MDS patientsJune 16, 2016AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Hematology TimesStudy reveals potential treatment avenue for DBA, MDSMay 12, 2016AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Hematology NewsRigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabineApril 13, 2016Myelodysplastic SyndromeAMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsRigosertib falls short for high-risk myelodysplastic syndromes after failure on azacitidine or decitabineApril 13, 2016Myelodysplastic SyndromeAMLLeukemia, Myelodysplasia, Transplantation
